Does Medicaid cover Ozempic?
Ozempic is a diabetes drug on Medicaid, and the statute treats it as one. No state can drop it for type 2 diabetes. What a state can do is decide which GLP-1 you try first, and refuse Ozempic for weight, which is not on its label.
Does Medicaid cover Ozempic?
Yes for type 2 diabetes, in every state: a diabetes drug is not something the statute lets a program exclude, so a state can only manage it, with a preferred-drug list or prior authorization. For weight, no — weight loss is not on Ozempic's label, and states that cover semaglutide for obesity cover it as Wegovy. 11 of 51 state programs cover a GLP-1 for obesity at all.
Type 2 diabetes: the only use on the label, and one no state can exclude
Every indication on Ozempic's label is in type 2 diabetes: glycemic control, reducing major cardiovascular events where heart disease is established, and slowing kidney decline in chronic kidney disease. None is weight loss, and the Social Security Act's list of drugs a state may exclude has no entry for diabetes. A state can still manage Ozempic: a preferred-drug list may make another GLP-1 the first choice, and prior authorization may ask for the diagnosis and a recent A1c.
What a state can refuse is Ozempic for weight alone, because that is off-label and weight loss is the excludable use. The semaglutide a state covers for obesity, where it covers any, is Wegovy — the same molecule under its weight label.
Ozempic is also now the name on Novo's semaglutide tablets for type 2 diabetes. On Medicaid, whether the tablet or the pen is the covered form is the state's preferred-drug list's decision, not the brand's.
Read from FDA prescribing information for OZEMPIC, via DailyMed and Social Security Act §1927(d)(2).
What each state's document says about Ozempic
What this site recorded for 1 of the 51 programs names Ozempic. Each line is from what this site recorded for that state, read from the document linked under it — covering states first.
North DakotaA weight-loss drug, but no GLP-1 for obesity
- No GLP-1 is covered for weight; Wegovy is approved only to reduce cardiovascular risk, for members aged 55 to 74 without diabetes, with a BMI of 27 to 35 and established cardiovascular disease, and only after Ozempic at 2 mg has been tolerated.
North Dakota Medicaid Preferred Drug List and Prior Authorization Criteria, version 2026.6, dated 2026-07-31; read 2026-09-10.
For weight, the states that cover this molecule name Wegovy, its weight-labeled sibling. Medicaid and Wegovy, state by state →
The card, and the cash price
The maker's savings card is not an option on Medicaid. Every manufacturer excludes government beneficiaries, because federal anti-kickback rules bar a maker from subsidizing a federal program's copay. If your state says no and you pay cash, Ozempic is $349 a month once titrated, read from its own published page on 2026-09-12.
If Medicaid says no
Federal Medicaid law requires an answer to a drug prior authorization within 24 hours, and a 72-hour emergency supply while it is pending. In a managed care plan you have 60 days from a denial to appeal to the plan, which must decide within 30 days, or 72 hours if it is urgent. On a decision the state makes itself, it may allow up to 90 days to ask for a fair hearing. Social Security Act §1927(d)(5); 42 CFR 438.402; 42 CFR 438.408; 42 CFR 431.221
What an Ozempic request has to show → The appeal letter builder fills in your state's own criteria and the fair-hearing rules.
Medicaid and Ozempic, answered
- Does Medicaid cover Ozempic?
- For type 2 diabetes, yes in every state: the statute gives a program no option to exclude a diabetes drug. A state can still require prior authorization, or a preferred GLP-1 first.
- Does Medicaid cover Ozempic for weight loss?
- No state has to, and weight loss is not on Ozempic's label. States that cover semaglutide for obesity cover it as Wegovy.
- Can I use the Ozempic savings card on Medicaid?
- No. Novo excludes government beneficiaries from it, as every manufacturer does under federal anti-kickback rules.